VivoSeq
Other

Radiation Therapy

0

Pipeline Programs↗

27

Active Trials↗

9

Companies Involved↗

Radiation Therapy is an early-stage landscape with 0 programs across 9 companies. The most active players are Radiation Therapy Oncology Group, Gynecologic Oncology Group, AstraZeneca.

Intelligence

Pipeline Metrics

Competitive Density

40/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

68/100

Attrition Rate

23/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Radiation Therapy Oncology Group logo

Radiation Therapy Oncology Group

0 programs

PreclinicalG

Gynecologic Oncology Group

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalL

Loma Linda Oncology Medical Group, Inc.

0 programs

PreclinicalSpectrum Pharmaceuticals, Inc logo

Spectrum Pharmaceuticals, Inc

0 programs

PreclinicalJohnson & Johnson Pharmaceutical Research & Development, L.L.C. logo

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

176

clinical trials

Completed86 · 49%
Terminated34 · 19%
Unknown status22 · 13%
Recruiting15 · 9%
Active, not recruiting9 · 5%
Withdrawn7 · 4%
Other3 · 2%

Clinical Trials

Trial Activity

176 trials

Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
Recruiting·ECOG-ACRIN Cancer Research Group·Phase 2·NCT03493425·82 enrolled
Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCL
Recruiting·TThe First Affiliated Hospital of Xiamen University·Phase 2·NCT06651853·22 enrolled
Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC
Recruiting·TTata Memorial Hospital·Phase 2·NCT05277844·106 enrolled
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery
Recruiting·MM.D. Anderson Cancer Center·Phase 1·NCT04169763·25 enrolled
68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.
Recruiting·PPeking Union Medical College Hospital·Phase 2·NCT06613269·40 enrolled
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
Recruiting·MMemorial Sloan Kettering Cancer Center·Phase 2·NCT05491512·121 enrolled
Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)
Recruiting·—·Phase 2·NCT05879653·30 enrolled
Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging
Recruiting·UUNICANCER·Phase 3·NCT06276465·336 enrolled
Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC
Recruiting·ZZhejiang Cancer Hospital·Phase 2·NCT06350162·100 enrolled
Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma
Recruiting·WWashington University School of Medicine·Phase 2·NCT04852328·30 enrolled
Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
Recruiting·JJonsson Comprehensive Cancer Center·Phase 1·NCT04703101·25 enrolled
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
Recruiting·SState University of New York - Upstate Medical University·Phase 1·NCT02619448·12 enrolled
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Recruiting·MMayo Clinic·Phase 2·NCT05541016·455 enrolled
Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC
Recruiting·—·Phase 2·NCT06379087·20 enrolled
Effectiveness of Virtual Reality in the Management of Anxiety for Patients Undergoing Radiotherapy
Recruiting·WWake Forest University Health Sciences·Preclinical·NCT07324577·54 enrolled
Page 1 of 12

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)